(833) 317-6278
Book a Demo
Jacob White
Gray shield icon
Is this you?
Claim your profile.

Jacob White

AS SEEN ON
dcatvci.org, The Lion's Roar, Diesel World Media, Dragzine.com

Preston's Summary

Jacob White is a journalist whose work has appeared in publications such as FantasyPros and Gridiron Experts. He specializes in covering news and developments in the biopharmaceutical industry, including mergers and acquisitions, manufacturing updates, and partnering news. Jacob provides in-depth analysis and reporting on the latest happenings in the pharmaceutical world.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Coverage Attributes:

Beta
Press Release: 45 %
Private Sector Announcements: 40 %
Government Announcement: 4 %
Industry Specific: 3 %
Cites Data: 1 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

Not enough data icon

Not enough data

Pitching Insights

Jacob White's articles primarily focus on press releases and private sector announcements related to the healthcare and pharmaceutical industry, with an emphasis on mergers and acquisitions. He frequently covers news about specific companies in the pharmaceutical industry, including their partnerships, manufacturing updates, and supplier relationships.

Given this focus, Jacob is likely to be interested in receiving pitches related to breaking news about mergers and acquisitions within the pharmaceutical industry or significant partnerships between major healthcare companies. Additionally, he may be open to receiving information about new developments from key suppliers or manufacturers within the sector.

Pitches should provide concise details of how a particular announcement or development contributes to broader trends within the healthcare and pharmaceutical landscape.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Alex Philippidis

Alex Philippidis

Senior Business Editor
**********is@***********com
Publications
Genetic Engineering & Biotechnology News
Most recent topics
Not enough data
Neil Versel

Neil Versel

Editor, Informatics
******l@**********com
Publications
Healthcare Dive
Most recent topics
Not enough data
Dan Stanton

Dan Stanton

Editor
*********on@*********om
Publications
BioProcess International, bioxconomy.com
Most recent topics
Not enough data
Millie Nelson

Millie Nelson

Publications
bioxconomy.com, BioProcess International
Most recent topics
Not enough data
Joseph Keenan

Joseph Keenan

Publications
Fierce Pharma
Most recent topics
Not enough data
Shreeyashi Ojha

Shreeyashi Ojha

Publications
BioProcess International
Most recent topics
Not enough data

Articles

BI, Synaffix in $1.3-Bn ADC Development Pact

By: Jacob White

Boehringer Ingelheim (BI) and Synaffix, an Oss, the Netherlands-based antibody drug conjugate (ADC) technology company and a subsidiary of Lonza, have formed an agreement under which BI has licensed Synaffix's ADC technology, in a deal worth up to $1.3 billion. Synaffix's technology platform includes payload and site-specific linker technologies, Lonza

J&J To Acquire Intra- Cellular Therapeutics for $14.6 Bn

By: Jacob White

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies, a Bedminster, New Jersey-based bio/pharmaceutical company focused on the development of therapeutics for central nervous system disorders, for $14.6 billion.

GSK To Acquire IDRx in $1.1-Bn Deal

By: Jacob White

GSK has agreed to acquire IDRx, a Boston-based, clinical-stage bio/pharmaceutical company, in a deal worth up to $1.1 billion ($1 billion upfront and $150 million in milestone payments).

Partnering News: Gilead, AbbVie & More

Partnering News: Gilead, AbbVie & More

By: Jacob White

Partnering News: Gilead, AbbVie & More A roundup of bio/pharmaceutical partnering news from Gilead Sciences/Leo Pharma, AbbVie/Simcere Zaiming, RegenxBio/NipponShinyaku and Emergent BioSolutions/Hikma/BARDA.

© 2025 Intelligent Relations